A status report on drug-associated acne and acneiform eruptions

Journal of Drugs in Dermatology

Volumn 9, Issue 6, 2010, Pages 627-636

  Momin, Saira B ^a   Peterson, Aaron ^b   Del Rosso, James Q ^a,c  

^a VALLEY HOSPITAL MEDICAL CENTER   (United States)

^b School of Medicine ^*

^c TOURO UNIVERSITY NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINEPTINE; ANABOLIC AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; AZATHIOPRINE; CHLORPROMAZINE; CORTICOSTEROID; CYCLOSPORIN; DACTINOMYCIN; DANAZOL; DANTROLENE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ETHIONAMIDE; ETRETINATE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDANTOIN; IMATINIB; IMIPRAMINE; LAMOTRIGINE; LEVONORGESTREL; LITHIUM CARBONATE; MAPROTILINE; NEUROLEPTIC AGENT; QUINIDINE; RAPAMYCIN; TESTOSTERONE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VALPROIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR;

ACNE; ACNE VULGARIS; ADVANCED CANCER; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ATOPIC DERMATITIS; CANCER RADIOTHERAPY; CHRONIC MYELOID LEUKEMIA; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE EXACERBATION; DRUG WITHDRAWAL; ENDOMETRIOSIS; FACIAL NERVE PARALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LARYNX SPASM; NEUTROPENIA; OUTCOME ASSESSMENT; PATHOGENESIS; PRECOCIOUS PUBERTY; PRURITUS; PSORIASIS; SOLID TUMOR; STEVENS JOHNSON SYNDROME; SURVIVAL TIME; ULCERATIVE COLITIS; URTICARIA; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; REVIEW;

ACNE VULGARIS; ACNEIFORM ERUPTIONS; ADRENAL CORTEX HORMONES; CYCLOSPORINE; DACTINOMYCIN; HUMANS; LITHIUM CARBONATE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIROLIMUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955877767     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Plewig G, Jansen T. Acneiform dermatoses. Dermatology. 1998;196:102-107. (Pubitemid 28116055)
2. Monk B, Cunliffe WJ, Layton AM, et al. Acne induced by inhaled corticosteroids. Clin Exp Dermatol. 1993;18:148-150. (Pubitemid 23098403)
3. Hughes JR, Higgins EM, Du Vivier AW. Acne associated with inhaled glucocorticosteroids. Br Med J. 1992;305:1000.
4. Smith MJ, Hodson ME. Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax. 1983;38:676-681. (Pubitemid 13043065)
5. Hengge UR, Ruzicka T, Schwartz RA, et al. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1-15.
6. Wells K, Brodell RT. Topical corticosteroids "addiction." A cause of perioral dermatitis. Postgrad Med. 1993;93:225-230.
7. Feldmann RJ, Maibach HI. Regional variation in percutaneous penetration of 14C cortisol in man. J Invest Dermatol. 1967;48:181-183.
8. Cohen HJ. Perioral dermatitis. J Am Acad Dermatol. 1981;4:739-740. (Pubitemid 11038011)
9. Kaidbey KH, Kligman AM. The pathogenesis of topical steroid acne. J Invest Dermatol. 1974;62:31-36.
10. Oliet EJ, Estes SA. Perianal comedones associated with chronic topical fluorinated steroid use. J Am Acad Dermatol. 1982;7:405-407. (Pubitemid 12051529)
11. Mills OH, Kligman AM. Acnegenicity of corticosteroids; Mode of action. Clin Res. 1974;22:330.
12. Kligman AM, Mills OH. Steroid acne. Dermatol Allergy. 1979;2:27-28.
13. Gloor M, Mildenberger KH. On the influence of an external therapy with dexamethasone-21-sodium-m-sulfobenzoate on the amount of free fatty acids in the skin surface lipids. Arch Dermatol Res. 1978;261:33-38. (Pubitemid 8276999)
14. Gloor M, Funder H, Franke M. Effect of topical application of dexamethasone on propionibacteria in the pilosebaceous duct. Eur J Clin Pharmacol. 1978;14:53-56. (Pubitemid 9069329)
15. Shibata M, Katsuyama M, Onodera T, et al. Glucocorticosteroids enhance toll-like receptor 2 expression in human keratinocytes stimulated with Propionibacteria acnes or proinflammatory cytokines. J Invest Dermatol. 2009; 129(2):375-382.
16. Tagami H. Unilateral steroid acne on the paralyzed side of the face. J Dermatol. 1983;10:281-282. (Pubitemid 13020217)
17. DeWitt CA, Siroy AE, Stone SP. Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy. J Am Acad Dermatol. 2007;56:500-505. (Pubitemid 46273854)
18. Segaert S, Van Cutsem E. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol. 2005;16:1425-1433. (Pubitemid 41222414)
19. Yalçin S, Dizdar O, Yalçin B, et al. Sparing of previously irradiated skin from erlotinib-induced acneiform rash. J Am Acad Dermatol. 2008;58:178-179. (Pubitemid 350298133)
20. Martin JM, Jordá E, Monteagudo C, et al. Follicular acneiform eruption induced by imatinib. J Eur Acad Dermatol Venereol. 2006;20:1368-1370. (Pubitemid 44614666)
21. Blatt J, Lee PA. Severe acne and hyperandrogenemia following dactinomycin. Med Pediatr Oncol. 1993;21:373-374. (Pubitemid 23152977)
22. Lee PK, Dover JS. Recurrent exacerbation of acne by granulocyte colony-stimulating factor administration. J Am Acad Dermatol. 1996;34:855-856.
23. Mahé E, Morelon E, Lechaton S, et al. Acne in recipients of renal transplantation treated with sirolimus: Clinical, microbiologic, histologic, therapeutic, and pathogenic aspects. J Am Acad Dermatol. 2006;55:139-142. (Pubitemid 43867022)
24. Mahé E, Morelon E, Lechaton S, et al. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation. 2005;79:476-482. (Pubitemid 40280181)
25. Bencini PL, Montagnino G, Sala F, et al. Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients. Dermatologica. 1986;172:24-30. (Pubitemid 16127742)
26. el-Shahawy MA, Gadallah MF, Massry SG. Acne: A potential side effect of cyclosporine A therapy. Nephron. 1996;72:679-682. (Pubitemid 26098273)
27. Azurdia RM, Graham RM, Weismann K, et al. Acne keloidalis in caucasian patients on cyclosporin following organ transplantation. Br J Dermatol. 2000;143:465-467. (Pubitemid 30650437)
28. De Gálvez Aranda MV, Sánchez PS, Alonso Corral MJ, et al. Acneiform eruption caused by amineptime. A case report and review of the literature. J Eur Acad Dermatol Venereol. 2001;15:337-339. (Pubitemid 33014847)
29. Bettoli V, Trimurti S, Lombardi AR, et al. Acne due to amineptine abuse. J Eur Acad Dermatol Venereol. 1998;10:281-283.
30. Fazio M, Afa G, Sacerdoti G, et al. Acne iatrogena da amineptina: Osservazioni cliniche e biochemiche. G Ital Dermatol Venereol. 1992;127:429-433.
31. Vexiau P, Gourmel B, Julien R, et al. Severe acne-like lesions caused by amineptine overdose. Lancet. 1988;1:585. (Pubitemid 18060499)
32. Farella V, Sberna F, Knöpfel B, et al. Acne-like eruption caused by amineptine. Int J Dermatol. 1996;35:892-893.
33. Chan HH, Wing Y, Su R, et al. A control study of the cutaneous side effects of chronic lithium therapy. J Affect Disord. 2000;57:107-113. (Pubitemid 30119963)
34. Kusumi Y. A cutaneous side effect of lithium: report of two cases. Dis Nerv Syst. 1971;32:853-854.
35. Rifkin A, Kurtin SB, Quitkin F, et al. Lithium-induced folliculitis. Am J Psychiatry. 1973;130:1018-1019.
36. Yoder FW. Letter: Acneiform eruption due to lithium carbonate. Arch Dermatol. 1975;111:396-397.
37. Kanzaki T. Acneiform eruption induced by lithium carbonate. J Dermatol. 1991;18:481-483.
38. Nielsen JN, Licht RW, Fogh K. Two cases of acneiform eruption associated with lamotrigine. J Clin Psychiatry. 2004;65:1720-1722.
39. Mishra B, Praharaj SK, Prakash R, et al. Aripiprazole-induced acneiform eruption. General Hospital Psychiatry. 2008; 30:479-481.
40. Burrows NP, Ratnavel RC, Norris PG. Pustular eruptions after chlorpromazine. Br Med J. 1994; 309:97. (Pubitemid 24216425)
41. Joffe H, Cohen LS, Suppes T, et al. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry. 2006;59:1078-1086. (Pubitemid 43849652)
42. Stankler L, Campbell AG. Neonatal acne vulgaris: A possible feature of the fetal hydantoin syndrome. Br J Dermatol. 1980;103:453-455. (Pubitemid 10029503)
43. Grunwald MH, Ben-Dor D, Livni E, et al. Acne keloidalis-like lesions on the scalp associated with antiepileptic drugs. Int J Dermatol. 1990;29:559-561. (Pubitemid 20345106)
44. Greenwood R, Fenwick PBC, Cunliffe WJ. Acne and anticonvulsants. Br Med J. 1983; 287:1669-70. (Pubitemid 14248506)
45. Stuttgen G. Zentralnervensystem und Talgsekretion. Archiv für Klinische und Experimentelle Dermatologie. 1964; 219:795-99.
46. Pembroke AC, Saxena SR, Kataria M, et al. Acne induced by dantrolene. Br J Dermatol. 1981;104:465-468.47.
47. Joynt RL. Dantrolene sodium: long-term effects in patients with muscle spasticity. Arch Phys Med Rehabil. 1976;57:212-217.
48. Sun G, Wasko CA, Hsu S. Acneiform eruption following anti-TNF-alpha treatment: A report of three cases. J Drugs Dermatol. 2008;7:69.
49. Bassi E, Poli F, Charachon A, et al. Infliximab-induced acne: Report of two cases. Br J Dermatol. 2007;156:402-403. (Pubitemid 46095989)
50. Pandya K, Babar R. Severe nodulocystic acne vulgaris in a patient on infliximab. J Am Acad Dermatol. 2006;52(suppl 2):126.
51. Krathen RA, Berthelot CN, Hsu S. Sustained efficacy and safety of infliximab in psoriasis: a retrospective study of 73 patients. J Drugs Dermatol. 2006;5:251-254.
52. Scott MJ Jr, Scott MJ III. Dermatologists and anabolic-androgenic drug abuse. Cutis. 1989;44:30-35.
53. Scott MJ III, Scott AM. Effects of anabolic-androgenic steroids on the pilosebaceous unit. Cutis. 1992;50:113-116.
54. Fyrand O, Fiskaadal HJ, Trygstad O. Acne in pubertal boys undergoing treatment with androgens. Acta Derm Venereol. 1992;72:148-149.
55. Traupe H, Von Mühlendahl KE, Brämswig J, et al. Acne of the fulminans type following testosterone therapy in three excessively tall boys. Arch Dermatol. 1988;124:414-417. (Pubitemid 18081602)
56. Luderschmidt C, Eiermann W, Jawny J. Steroid hormone receptors and their relevance for sebum production in the sebaceous gland ear model of the Syrian hamster. Arch Dermatol Res. 1983;275:175-180. (Pubitemid 13056613)
57. Heydenreich G. Testosterone and anabolic steroids and acne fulminans. Arch Dermatol. 1989;125:571-572.
58. Greenberg RD. Acne vulgaris associated with antigonadotropic (Danazol) therapy. Cutis. 1979;24:431-433.
59. Dmowski WP, Cohen MR. Treatment of endometriosis with an antigonadotropin, danazol. Obstet Gynecol. 1975;46:147.
60. Lauersen NH, Wilson KH, Birnbaum S. Danazol: An antigonadotropic agent in the treatment of pelvic endometriosis. Am J Obstet Gynecol. 1975;123:742.
61. Olsson SE, Odlind V, Johansson E. Androgen levels in women using Norplant implants. Contraception. 1986;34:157-167. (Pubitemid 17178979)
62. Menter A, Boyd A. Cystic acne in psoriatic patients undergoing etretinate therapy. J Am Acad Dermatol. 1988;18:751-752.
63. Lowe L, Herbert AA. Cystic and comedonal acne: A side effect of etretinate therapy. Int J Dermatol. 1989;28:482. (Pubitemid 19225383)
64. Bereston ES. Reactions to antituberculous drugs. J Invest Dermatol. 1959;33:427-439.
65. Cohen LK, George W, Smith R. Isoniazid-induced acne and pellagra. Occurrence in slow inactivators of isoniazid. Arch Dermatol. 1974;109:377-381.
66. Holdiness MR. Adverse cutaneous reactions to antituberculosis drugs. Int J Dermatol. 1985;24:280-285. (Pubitemid 15062922)
67. Burkhart CG. Quinidine-induced acne. Arch Dermatol. 1981;117:603-604. (Pubitemid 11022579)
68. Bakos L, Bakos RM. Focal acne during topical tacrolimus therapy for vitiligo. Arch Dermatol. 2007;143:1223-1224. (Pubitemid 47443398)
69. Antille C, Saurat JH, Lübbe J. Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. Arch Dermatol. 2004;140:457-460. (Pubitemid 38469249)
70. Bajwa ZH, Sami N, Flory C. Severe acne as a side effect of propranolol and nadolol in a migraineur. Headache. 1999;39:758-760. (Pubitemid 30075086)
71. Ismail R. Acne fulminans with dapsone induced haemolysis: A case report. Med J Malaysia. 1987;42:124-126.
72. Schmoeckel C, Von Liebe V. Acneiform exanthema caused by azathioprine. Hautarzt. 1983;34:413-415.
73. Hjortshoj A. Lichen planus and acne provoked by gold. Acta Derm Venereol. 1977;57:165-167. (Pubitemid 8057629)
74. Jones C, Bleehen SS. Acne induced by PUVA treatment. Br Med J. 1977;2:866. (Pubitemid 8187373)
75. Nielsen EB, Thormann J. Acne-like eruptions induced by PUVA-treatment. Acta Derm Venereol. 1978;58:374-375. (Pubitemid 9008713)
76. Frumess GM, Lewis HM. Light-sensitive seborrheid. Arch Derm. 1957;75:245-248.
77. Hjorth N, Sjolin KE, Sylvest B, et al. Acne aestivalis-Mallorca acne. Acta Derm Venereol. 1972;52:61-63.
78. Sherertz EF. Acneiform eruption due to "megadose" vitamins B6 and B12. Cutis. 1991;48:119-120.
79. Braun-Falco O, Lincke H. The problem of vitamin B6/B12 acne. A contribution on acne medicamentosa. MMW Munch Med Wochenschr. 1976;118:155-160.
80. Barefoot SW. Acneiform eruption produced by use of tetraethylthiuramdisulfide. JAMA. 1951;147:1653.
81. Webster GF. Pustular drug reactions. Clin Dermatol. 1993;11:541-543. (Pubitemid 24024939)
82. Fisher AA. Drug eruptions in geriatric patients. Cutis. 1976;18:402-409.
83. Tindall JP. Chloracne and chloracnegens. J Am Acad Dermatol. 1985;13:539-558. (Pubitemid 15246634)
84. Panteleyev AA, Bickers DR. Dioxin induced chloracne - Reconstructing the cellular and molecular mechanisms of a classic environmental disease. Exp Dermatol. 2006;15:705-730. (Pubitemid 44145241)
85. Frankel EB. Acne secondary to white petrolatum use. Arch Dermatol. 1985;121:589-590. (Pubitemid 15062706)
86. O'Brien TJ. Acneiform eruption associated with the use of a cow udder ointment. Australas J Dermatol. 1990;31:119.